PL2801373T3 - Lek do podawania miejscowego w leczeniu zaburzeń połykania - Google Patents

Lek do podawania miejscowego w leczeniu zaburzeń połykania

Info

Publication number
PL2801373T3
PL2801373T3 PL12859657T PL12859657T PL2801373T3 PL 2801373 T3 PL2801373 T3 PL 2801373T3 PL 12859657 T PL12859657 T PL 12859657T PL 12859657 T PL12859657 T PL 12859657T PL 2801373 T3 PL2801373 T3 PL 2801373T3
Authority
PL
Poland
Prior art keywords
local administration
type pharmaceutical
improving dysphagia
dysphagia
improving
Prior art date
Application number
PL12859657T
Other languages
English (en)
Inventor
Koichi Kitamura
Maho Kondo
Kiyoshi Shimoyama
Toru Kurosawa
Original Assignee
Meiji Seika Pharma Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Pharma Co., Ltd. filed Critical Meiji Seika Pharma Co., Ltd.
Publication of PL2801373T3 publication Critical patent/PL2801373T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Psychology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL12859657T 2011-12-21 2012-12-20 Lek do podawania miejscowego w leczeniu zaburzeń połykania PL2801373T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011280365 2011-12-21
EP12859657.4A EP2801373B1 (en) 2011-12-21 2012-12-20 Local administration-type pharmaceutical for improving dysphagia

Publications (1)

Publication Number Publication Date
PL2801373T3 true PL2801373T3 (pl) 2017-07-31

Family

ID=48668562

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12859657T PL2801373T3 (pl) 2011-12-21 2012-12-20 Lek do podawania miejscowego w leczeniu zaburzeń połykania

Country Status (8)

Country Link
US (2) US9675547B2 (pl)
EP (1) EP2801373B1 (pl)
JP (1) JP5828007B2 (pl)
KR (1) KR101896441B1 (pl)
CN (3) CN104125837A (pl)
ES (1) ES2616960T3 (pl)
PL (1) PL2801373T3 (pl)
WO (1) WO2013094682A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2801373T3 (pl) * 2011-12-21 2017-07-31 Meiji Seika Pharma Co., Ltd. Lek do podawania miejscowego w leczeniu zaburzeń połykania
JPWO2014199486A1 (ja) * 2013-06-13 2017-02-23 Meiji Seikaファルマ株式会社 嚥下障害改善用医薬品
US9974768B2 (en) 2013-06-13 2018-05-22 Meiji Seika Pharma Co., Ltd. Pharmaceutical for improving dysphagia

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824477B1 (fr) 2001-05-09 2005-09-09 Ethypharm Lab Prod Ethiques Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes
JP2004107285A (ja) 2002-09-20 2004-04-08 Mercian Corp 嚥下障害改善剤
JP2006511617A (ja) 2002-12-13 2006-04-06 アダーギット 製薬用多孔質粒子
CN100431553C (zh) * 2002-12-26 2008-11-12 株式会社山田养蜂场本社 改善咽下障碍用组合物
US8992974B2 (en) * 2003-02-24 2015-03-31 Pharmaceuticals Productions, Inc. Transmucosal drug delivery system
JP2004300403A (ja) 2003-03-18 2004-10-28 Jsr Corp (メタ)アクリル系重合体および感放射線性樹脂組成物
JP3762969B2 (ja) 2003-03-31 2006-04-05 株式会社東北テクノアーチ 嚥下障害改善剤
WO2005099670A1 (en) * 2004-03-31 2005-10-27 Richard Soltero Method for administering medicaments to subjects with swallowing difficulties and disorders
EP2767163A1 (en) 2005-02-17 2014-08-20 Abbott Laboratories Transmucosal administration of drug compositions for treating and preventing disorders in animals
JP5366558B2 (ja) 2006-12-28 2013-12-11 武田薬品工業株式会社 口腔内崩壊性固形製剤
US20100221340A1 (en) * 2007-09-20 2010-09-02 University Of Rochester Method and compositions for treatment or prevention of inflammatory conditions
GB0801876D0 (en) 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
GB0900622D0 (en) * 2009-01-15 2009-02-25 Williams Paul A method for diagnosing urticaria and angioedema
EP2429495A4 (en) 2009-05-15 2014-01-22 Shin Nippon Biomedical Lab Ltd INTRANASAL PHARMACEUTICAL COMPOSITION WITH IMPROVED PHARMACOKINETICS
PL2801373T3 (pl) * 2011-12-21 2017-07-31 Meiji Seika Pharma Co., Ltd. Lek do podawania miejscowego w leczeniu zaburzeń połykania
US9974768B2 (en) * 2013-06-13 2018-05-22 Meiji Seika Pharma Co., Ltd. Pharmaceutical for improving dysphagia

Also Published As

Publication number Publication date
US20170266111A1 (en) 2017-09-21
JPWO2013094682A1 (ja) 2015-04-27
HK1200108A1 (en) 2015-07-31
EP2801373A4 (en) 2015-10-07
CN108853093A (zh) 2018-11-23
US20150297512A1 (en) 2015-10-22
US9675547B2 (en) 2017-06-13
WO2013094682A1 (ja) 2013-06-27
ES2616960T3 (es) 2017-06-14
KR20140116105A (ko) 2014-10-01
US10052281B2 (en) 2018-08-21
KR101896441B1 (ko) 2018-09-11
CN107049997A (zh) 2017-08-18
EP2801373A1 (en) 2014-11-12
JP5828007B2 (ja) 2015-12-02
CN104125837A (zh) 2014-10-29
EP2801373B1 (en) 2017-02-08

Similar Documents

Publication Publication Date Title
AP3864A (en) Pharmaceutical composition
DK3505720T3 (en) Cementering under styret tryk
SG10201601802YA (en) Dispiropyrrolidine derivatives
GB201109414D0 (en) Diathermy -ionisation technique
IL231229A0 (en) New history of dihydroquinoline-2-one
LT2729179T (lt) Makromolekulės
ZA201307273B (en) Merchandiser
GB201118232D0 (en) Pharmaceutical composition
SG11201401937YA (en) New aryl-quinoline derivatives
IL247640A0 (en) History of heteroaryl piperidine
ZA201308157B (en) Pharmaceutical composition
EP2727593A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL
SI2766342T1 (sl) Derivati fenil-gvanidina
EP2716258A4 (en) INTRASTOMAL SEGMENT
EP2711010A4 (en) PHARMACEUTICAL COMPOSITION
PL2801373T3 (pl) Lek do podawania miejscowego w leczeniu zaburzeń połykania
ZA201308049B (en) 3-ureidoisoquinolin-8-yl derivatives
PL2665867T3 (pl) Tor
HUP1100444A2 (en) Pharmaceutical composition
ZA201305677B (en) Passage barrier
HUP1100445A2 (en) Pharmaceutical composition
GB201119796D0 (en) Pharmaceutical comopounds
IL215425A0 (en) Anti-vchicle barrier
GB201105337D0 (en) Barrier
PL119701U1 (pl) Bariera